Han E, Huh JH, Lee EY, Bae JC, et al. Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Multicenter, Double-blind, Randomized, Comparative trial. Diabetes Obes Metab 2021 Dec 17. doi: 10.1111/dom.14623.
PMID: 34918436